Publications by authors named "Maria Baggstrom"

Claim this Profile
R
Racialized economic segregation and disparities in non-small cell lung cancer care and outcomes.
Pratibha Shrestha, Min Lian, James Struthers, Oumarou Nabi, Bayu B Bekele, Maria Baggstrom

CHEST Pulm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer.
Bayu B Bekele, Min Lian, Pratibha Shrestha, Oumarou Nabi, Benjamin Kozower, Maria Q Baggstrom

Cancer Epidemiol Biomarkers Prev· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Women in Medicine Programs at University-Based Internal Medicine Residency Programs.
Shinji Rho, Alyssa Rust, Lydia Zhong, Koeun Lee, Abby Spencer, Maria Q Baggstrom

South Med J· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investing in Women Trainees: Building a Women in Medicine Group at an Academic Institution.
Lydia Zhong, Koeun Lee, Maria Q Baggstrom, Rakhee K Bhayani

J Med Internet Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer.
Jessika Contreras, Amar Srivastava, Pamela Samson, Todd DeWees, Ramaswamy Govindan, Maria Q Baggstrom

Int J Radiat Oncol Biol Phys· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors.
Nusayba A Bagegni, Haeseong Park, Katlyn Kraft, Maura O-Toole, Feng Gao, Maria Q Baggstrom

Cancer Chemother Pharmacol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies.
Kian-Huat Lim, Mateusz Opyrchal, Abhi Acharya, Nick Boice, Ningying Wu, Maria Q Baggstrom

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors.
Manik Amin, Feng Gao, Gretel Terrero, Joel Picus, Andrea Wang-Gillam, Maria Baggstrom

Am J Clin Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of everolimus in patients with advanced solid malignancies with or mutations.
Siddhartha Devarakonda, Bruna Pellini, Luke Verghese, Haeseong Park, Daniel Morgensztern, Maria Q Baggstrom

J Thorac Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy.
Susanne M Arnold, Kari Chansky, Maria Q Baggstrom, Michael A Thompson, Rachel E Sanborn

Clin Lung Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.
Thomas E Stinchcombe, Pasi A Jänne, Xiaofei Wang, Erin M Bertino, Jared Weiss, Maria Q Baggstrom

JAMA Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer.
Lecia V Sequist, Jhanelle Elaine Gray, Wael A Harb, Ariel Lopez-Chavez, Robert C Doebele, Maria Quintos Baggstrom

Oncologist· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553).
Susanne M Arnold, Kari Chansky, Markos Leggas, Michael A Thompson, John L Villano, Maria Q Baggstrom

Invest New Drugs· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC.
David E Gerber, Paul Swanson, Ariel Lopez-Chavez, Lucas Wong, Afshin Dowlati, Maria Q Baggstrom

Lung Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulsatile Erlotinib in EGFR-Positive Non-Small-Cell Lung Cancer Patients With Leptomeningeal and Brain Metastases: Review of the Literature.
Joan How, Janelle Mann, Andrew N Laczniak, Maria Q Baggstrom

Clin Lung Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).
Martin J Edelman, Xiaofei Wang, Lydia Hodgson, Richard T Cheney, Maria Q Baggstrom

J Clin Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance).
Maria Q Baggstrom, Mark A Socinski, Xiaofei F Wang, Lin Gu, Thomas E Stinchcombe

J Thorac Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung Cancer.
Saiama N Waqar, Maria Q Baggstrom, Daniel Morgensztern, Kristina Williams, Caron Rigden

Chemotherapy· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC.
Daniel Morgensztern, Lingling Du, Saiama N Waqar, Aalok Patel, Pamela Samson, Maria Baggstrom

J Thorac Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed nausea and vomiting from carboplatin doublet chemotherapy.
Saiama N Waqar, Janelle Mann, Maria Q Baggstrom, Muhammad Atif Waqar, Pooja Chitneni

Acta Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).
Neal E Ready, Herbert H Pang, Lin Gu, Gregory A Otterson, Sachdev P Thomas, Maria Baggstrom

J Clin Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.
Cliff G Robinson, Aalok P Patel, Jeffrey D Bradley, Todd DeWees, Saiama N Waqar, Maria Q Baggstrom

J Clin Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical next-generation sequencing in patients with non-small cell lung cancer.
Ian S Hagemann, Siddhartha Devarakonda, Christina M Lockwood, David H Spencer, Kalin Guebert, Maria Baggstrom

Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies.
Andrea Wang-Gillam, Nilay Thakkar, A Craig Lockhart, Kerry Williams, Maria Baggstrom

Cancer Chemother Pharmacol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer.
Maria Q Baggstrom, Yingwei Qi, Marianna Koczywas, Athanassios Argiris, Elizabeth A Johnson

J Thorac Oncol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis